Virginia-based Indivior to invest $60M in Raleigh manufacturing plant

Indivior, a global pharmaceutical company based in North Chesterfield, Va., will expand into North Carolina with a $60 million investment in a sterile manufacturing plant over the next five years. 

The company will develop a facility at 8900 Capital Blvd. in Raleigh previously owned by Sagent Pharmaceuticals and will retain Sagent’s current workforce while adding 35 new positions, according to a news release. 

Key roles at the plant will span production, quality control, maintenance and engineering.

“This facility and its skilled workforce will help us secure diversified long-term supply for our products, and we are pleased to now be a member of the thriving Raleigh and Wake County business communities,” said Mark Crossley, chief executive officer of Indivior.

The facility includes about 80,000 square feet of laboratory and production space previously used by Sagent for thIndivior logoe manufacture of injectable medicines. Sagent acquired the plant in 2019 from Xellia Pharmaceuticals, which employed about 120 people there at the time.

Sagent was recently sold by its Japanese owner, Nichi-Iko Pharmaceutical Co., to Ellimist Singapore, an asset management firm, according to a March report in Generics Bulletin, a pharmaceutical industry publication.

Making medicines for substance use disorders

Indivior develops medicines to treat substance use disorders and other serious mental illnesses. Its products are sold in 39 countries and include treatments for opioid use disorder. Other products are in development for treating opioid, alcohol and cannabis use disorders.

Indivior employs more than 1,000 people globally. Its stock (INDV) began trading on the Nasdaq Global Select Market in June and is also listed on the London Stock Exchange.

“The City of Raleigh supports fostering growth among our local businesses,” Mayor Mary-Ann Baldwin said in the announcement. “We purposefully cultivate a cooperative, inclusive, and economically supportive environment for local companies and welcome Indivior Inc.”

Shinica Thomas, chair of the Wake County Board of Commissioners, said, “In Wake County, we prioritize equitable economic development. The expansion of this life science facility will retain and create new jobs in one of the county’s Targeted Growth Areas.”

Partners for Indivior’s recruitment included the City of Raleigh, Wake County, Raleigh Economic Development, Wake County Economic Development, Raleigh Chamber, Economic Development Partnership of North Carolina, North Carolina Department of Commerce Division of Workforce Solutions, North Carolina Community College System, Capital Area Workforce Development and Wake Tech Community College.

Barry Teater, NCBiotech Writer
scroll back to top of page